New Pilot Project Program grants from Women’s Health Research at Yale will focus on two fundamental and important areas of women’s health: breast cancer, the second leading cause of cancer mortality among women; and obesity, which in women leads to higher...
Yale Cancer Center is pleased to announce the appointment of Louis Chênevert as Chairman of the Center’s Advisory Board. Mr. Chênevert is Chairman and Chief Executive Officer of United Technologies Corp. (NYSE:UTX).“Yale Cancer Center is a critical asset...
Forty-nine members of Yale Medical Group (YMG), the clinical practice of the faculty of Yale School of Medicine, are included in New York Magazine’s list of Best Doctors for 2011, far outnumbering any other practice or hospital in Connecticut. The list is...
Renowned glaucoma specialist M. Bruce Shields, M.D., the Marvin Sears Professor and Chair Emeritus of Ophthalmology and Visual Science at Yale School of Medicine, will be honored June 17 with an international ophthalmology symposium as he retires after 15...
The precise wiring of our visual system depends upon the pattern of spontaneous activity within the brain that occurs well before birth, a new study by Yale researchers shows.“It isn’t just the genes. What happens within the womb is crucial,” said Michael...
An estimated 20 million people in the United States suffer from peripheral neuropathy, marked by the degeneration of nerves and in some cases severe pain. There is no good treatment for the disorder and doctors can find no apparent cause in one of every...
In one of the first studies to examine the reasons for the rising number of women delivering their babies by cesarean section, Yale School of Medicine researchers found that while half of the increase was attributable to a rise in repeat cesarean delivery...
A team of Yale Cancer Center researchers has confirmed that between 10-20% of breast cancers classified as Estrogen Receptor (ER) negative are really positive. Understanding when and why breast cancers may be misclassified has important implications for...
There is a 17% greater risk of dying after a heart attack if you are treated in a hospital located in a U.S. territory-i.e. the U.S. Virgin Islands, Guam, Puerto Rico, American Samoa, and Northern Mariana Islands-rather than in a hospital in the mainland...
Yale School of Medicine researchers have found that a clinical trial of the epilepsy drug gabapentin may have been a “seeding trial” used by a pharmaceutical company to promote the drug and increase prescriptions, according to a report in the June issue...